In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial-Reference-Cited by-同舟云学术

In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial

Published:2013-11 Issue:11 Volume:19 Page:1638-1649
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Koura Divya T.,Horan John T.,Langston Amelia A.,Qayed Muna,Mehta Aneesh,Khoury Hanna J.,Harvey R. Donald,Suessmuth Yvonne,Couture Cynthia,Carr Jennifer,Grizzle Audrey,Johnson Heather R.,Cheeseman Jennifer A.,Conger Jason A.,Robertson Jennifer,Stempora Linda,Johnson Brandi E.,Garrett Aneesah,Kirk Allan D.,Larsen Christian P.,Waller Edmund K.,Kean Leslie S.

Funder

Aflac Cancer and Blood Disorders Center of the Department of Pediatrics, Emory University School of Medicine

Burroughs Wellcome Fund

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference44 articles.

1. Risk factors for acute GVHD and survival after hematopoietic cell transplantation;Jagasia;Blood,2012

2. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review;Weisdorf;Biol Blood Marrow Transplant,2003

3. Quality of life associated with acute and chronic graft-versus-host disease;Lee;Bone Marrow Transplant,2006

4. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood,2007

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD;Cells;2024-09-11

2. Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19;JAMA Network Open;2024-04-25

3. Immunomodulation by juglone alleviates acute graft‐versus‐host disease without compromising the graft‐versus‐leukaemia activity in mice;British Journal of Pharmacology;2024-04-07

4. A Difficult Case of Calcineurin Inhibitor Neurotoxicity Post-Haploidentical HCT With a Successful Novel Solution: Cytotoxic T-Lymphocyte-Associated Protein 4-Immunoglobulin Blockade for GVHD Prophylaxis;Cell Transplantation;2024-01

5. Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events;Blood;2023-08-24